U S Stem Cell Inc (USRM) Return on Investment ROI from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
U s Stem Cell Inc   (NONE: USRM)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


U S Stem Cell Inc's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is U S Stem Cell Inc's ROI in the fourth quarter of 2022?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate U S Stem Cell Inc 's return on investment (ROI) in its fourth quarter of 2022

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -14 -13 -13 -13 -9
Return On Investment (TTM) - - - - -
USRM's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -3 -3 -3 -3 -3

USRM Company Profile >> Back to USRM Roi Comparisons >> See Annual USRM Return On Investment



Return On Investment USRM's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
U S Stem Cell Inc's IV. Quarter Investments $ -14 Millions USRM's Balance sheet
U S Stem Cell Inc's IV. Quarter Income $ -1 Millions Quarterly USRM's Income Statement
USRM's Income by Division See USRM's Income by Division


USRM Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions -14 -12 -11 -9 -4
Y / Y Investment Growth - - - - -
Net Income in Millions -3 -3 -3 -4 -2
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
USRM's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for USRM's Competitors
Subscribers only: Roi for U S Stem Cell Inc's Suppliers
Subscribers only: Return On Investment for USRM's Customers

Other Ratios
USRM's Roa USRM's Inventory Turnover Ratio USRM's Growth Rates USRM's Dividend Statistics
USRM's Profitability Ratios USRM's Asset Turnover Ratio USRM's Dividend Growth
USRM's Roe USRM's Valuation Ratios USRM's Financial Strength Ratios USRM's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI
Biomx Inc  57.59 %
Dariohealth Corp   54.89 %
Sensus Healthcare Inc   51.84 %
Shockwave Medical Inc   51.53 %
Molecular Partners Ag  46.72 %
Assertio Holdings inc   45.06 %
Biontech Se  44.93 %
Vaso Corporation  44.13 %
Idexx Laboratories Inc  43.77 %
Moderna Inc   43.00 %
Dynavax Technologies Corporation  41.67 %
Fuse Medical Inc   40.18 %
Harmony Biosciences Holdings inc   36.66 %
Mettler toledo International Inc   35.49 %
Medpace Holdings Inc   34.89 %
Zymeworks Inc   34.67 %
Nrc Health  31.87 %
Aptevo Therapeutics Inc   31.31 %
Point Biopharma Global Inc   31.14 %
Catalyst Pharmaceuticals Inc   30.87 %
Avid Bioservices Inc   29.58 %
Inmode Ltd   28.72 %
Alpha Tau Medical Ltd  27.80 %
Semler Scientific inc   27.48 %
Cartesian Therapeutics Inc   24.44 %
Vertex Pharmaceuticals Inc  24.33 %
Orgenesis Inc   23.86 %
Prophase Labs Inc   22.95 %
Vir Biotechnology Inc   22.24 %
Corcept Therapeutics Inc  21.91 %

Date modified: 2026-09-08T15:10:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.